Welcome to May’s On Rotation!It’s been a busy month, to say the least, featuring a CEO shake-up at two top companies: Novo Nordisk and UnitedHealth Group.
Though those dramatic exits dominated headlines, there have been quite a few other high-profile career switches this month, and we’re bringing them to you!
Here’s a noncomprehensive roundup of some of the past month’s career shifts, from startups to megacorporations.
Nicholas Botwood: After 10 years at Bristol Myers Squibb—most recently as SVP of medical oncology—Botwood has left to head R&D and serve as chief medical officer at Syndax, a biopharmaceutical company focused on innovative cancer therapies, the company announced May 12.
Sumeet Chugh: The heart rhythm expert has been promoted to vice dean and chief artificial intelligence health research officer at Los Angeles-based Cedars-Sinai, the health system announced May 6.
Karen DeSalvo: Google’s chief health officer announced earlier this month on LinkedIn she plans to retire Aug. 1 after more than five years at the company. She’ll be succeeded by Michael Howell, who’s been chief clinical officer and deputy chief health officer since 2020.
Sarah Fraser: On May 8, Centivo, a health plan for self-funded employers, announced it had appointed Fraser as its inaugural CFO. She previously served as CFO of digital pharmacy Capsule.
Nader Kabbani: Telehealth platform Hims & Hers announced May 5 that Kabbani, an Amazon executive of nearly 20 years, is its new chief operations officer, following the retirement of Melissa Baird’s transition to an advisory role.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
Creagh Milford: CVS Health has named Milford president of its chain of primary care centers, Oak Street Health, he shared in a LinkedIn post on May 19. He’s been with CVS for more than three years, most recently as president of retail health.
Thomas Pike: Global contract research organization Fortrea is saying goodbye to its CEO and chairman of the board. Peter Neupert, Fortrea’s lead independent director, took over as interim CEO and board chair on May 13. Pike will stay on as a consultant to aid the transition.
John Whyte: On May 9, the American Medical Association announced Whyte, a practicing physician of 27 years, will be its next CEO and EVP starting July 1. He’ll replace James Madara, who had a 14-year tenure.
Ilya Yuffa: Eli Lilly is playing musical chairs with its executive leadership team. The company announced May 8 Yuffa will be EVP and president of Lilly USA and global customer capabilities. His old role—EVP and president of Lilly International—will go to Patrik Jonsson, who was also president of Lilly USA. Jonsson’s old role—EVP and president of Lilly Cardiometabolic Health—will go to Kenneth Custer, who is currently general manager of Lilly Canada.